The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial
Addiction · 2026-08 · 121 (8) · 2071-2082
DOI: 10.1111/add.70412 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Addiction, online erschienen am 14.04.2026. Verfasst von Suzanne Nielsen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Monash Addiction Research Centre (MARC), Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Naloxone, Analgesics, Opioid, Narcotic Antagonists, Patient Education as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government-Department of Health and Aged Care, National Health and Medical Research Council.
Abstract (Originalsprache)
Background and aims Prescription opioid‐related harm remains a significant public health concern. This study aimed to evaluate the efficacy of the Opioid Safety Toolkit, a co‐designed, interactive online resource, in increasing naloxone uptake and healthcare provider discussions among adults prescribed opioids for pain.
Design
Parallel‐group, open‐label, randomised controlled trial.
Setting
Community‐based, online recruitment across Australia.
Participants
Adults ( n = 314) prescribed opioids for non‐cancer pain.
Interventions
Participants were randomised to receive either the Opioid Safety Toolkit (intervention, n = 152), which included interactive and tailored educational content on opioid safety, or an active control website presenting evidence‐based opioid safety information ( n = 162). Both groups were followed for four weeks.
Measurements
The primary outcome was self‐reported naloxone requests four weeks post‐intervention. Other outcomes were intentions to access naloxone immediately post‐intervention, and healthcare provider discussions about opioid safety at four weeks, opioid safety knowledge (immediately after the intervention and at four weeks), satisfaction with resources and naloxone possession at four weeks.
Findings
Participants in the intervention group were more likely to have requested naloxone at four weeks compared with controls [21.7% vs 9.9%, odds ratio (OR) = 2.5, 95% confidence interval (CI) = 1.3, 4.8; P = 0.005], and more likely to report intentions to access naloxone immediately post‐intervention compared with controls (41.4% vs 15.4%, OR = 3.9, 95% CI = 2.3, 6.6; P < 0.001). Participants in the intervention group were not more likely to have healthcare provider discussions at four weeks compared with controls (OR = 1.1, 95% CI = 0.7, 1.8; P = 0.620). Post‐intervention opioid overdose knowledge was statistically significantly higher in the intervention group compared with control group (Mean score 16.6, 95% CI = 15.5, 17.7 vs control mean score 13.3, 95% CI = 12.3, 14.3). Satisfaction with the resource was higher in the intervention group compared with control group (Mean = 20.0, 95% CI = 18.7, 21.3 vs Mean = 18.0, 95% CI = 16.7, 19.3, P = 0.035).
Conclusions
We found good evidence that, compared with a gold‐standard opioid information website, the Opioid Safety Toolkit increased naloxone requests among Australian adults prescribed opioids for non‐cancer pain. We also observed consistent effects across secondary outcomes, with the Toolkit increasing intentions to access naloxone, enhancing opioid overdose knowledge and yielding higher satisfaction ratings, although it did not increase healthcare provider discussions at four weeks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Monash Addiction Research Centre (MARC), Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
- Action Lab, Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia.
- School of Public Health and Social Development, Deakin University, Melbourne, Victoria, Australia.
- Pharmaceutical Society of Australia, Melbourne, Victoria, Australia.
- Burnet Institute, Melbourne, Victoria, Australia.
ORCID-Profile: Suzanne Nielsen, Frederick Fox, Tina Lam, Monica Jung, Louisa Picco
Förderung
- Australian Government-Department of Health and Aged Care
- National Health and Medical Research Council
Zitieren
APA
Nielsen, S., Fox, F., Lam, T., Waddell, A., Jung, M., Rowland, B., Watterson, J., Basur, D., Prawira, C., Seguin, J. P., Olivier, P., McMaugh, J., Dietze, P., & Picco, L. (2026). The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial. Addiction, 121(8), 2071-2082. https://doi.org/10.1111/add.70412
Vancouver
Nielsen S, Fox F, Lam T, Waddell A, Jung M, Rowland B, et al. The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial. Addiction. 2026;121(8):2071-2082. doi:10.1111/add.70412
BibTeX
@article{Nielsen2026,
author = {Nielsen, Suzanne and Fox, Frederick and Lam, Tina and Waddell, Alex and Jung, Monica and Rowland, Bosco and Watterson, Jessica and Basur, Dhruv and Prawira, Chris and Seguin, Joshua Paolo and Olivier, Patrick and McMaugh, Jarrod and Dietze, Paul and Picco, Louisa},
title = {The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial},
journal = {Addiction},
year = {2026},
volume = {121},
number = {8},
pages = {2071--2082},
doi = {10.1111/add.70412}
}
EUVIMED